Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

469
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
469
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

190
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

417
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
417
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

378
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
378

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the United States' Permitless Concealed Carry Laws and Child Health in the ECHO Cohort.

Health and human rights·2026
Same author

Prenatal Air Pollution Exposure and Autism Spectrum Disorder in the ECHO Consortium.

Environmental health perspectives·2026
Same author

Prenatal over-the-counter acetaminophen use and birth outcomes in the ECHO cohort.

American journal of epidemiology·2026
Same author

Neonatal inflammation predicts adolescent brain volume and neurologic outcomes in children born extremely prematurely.

Scientific reports·2026
Same author

Perceived Caregiver Discrimination and Neurocognitive Development: An Analysis from the ECHO Cohort.

Journal of racial and ethnic health disparities·2026
Same author

Self-reported positive health outcomes during the COVID-19 pandemic among adolescents born preterm in the ECHO cohort.

Journal of perinatology : official journal of the California Perinatal Association·2026

Related Experiment Video

Updated: Oct 3, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.5K

Extreme prematurity: Risk and resiliency.

Genevieve L Taylor1, T Michael O'Shea2

  • 1Genevieve L Taylor MD: Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of North Carolina School of Medicine.

Current Problems in Pediatric and Adolescent Health Care
|February 19, 2022
PubMed
Summary

Infants born extremely preterm face higher risks of neurodevelopmental disorders. Interventions aim to prevent premature birth and improve outcomes for these vulnerable children.

More Related Videos

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

10.5K
The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation
09:03

The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation

Published on: August 15, 2018

11.0K

Related Experiment Videos

Last Updated: Oct 3, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.5K
A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

10.5K
The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation
09:03

The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation

Published on: August 15, 2018

11.0K

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Public Health

Background:

  • Extremely preterm birth (before 28 weeks) is rare but disproportionately affects children with neurodevelopmental disorders.
  • Conditions include cerebral palsy, intellectual deficit, autism, ADHD, and epilepsy.
  • This review focuses on two major cohorts: EPICURE (UK/Ireland) and ELGAN (US).

Purpose of the Study:

  • To review neurodevelopmental outcomes in extremely preterm infants.
  • To identify early life and prenatal risk factors.
  • To summarize current interventions for improving life course outcomes.

Main Methods:

  • Analysis of data from the EPICURE and ELGAN cohorts.
  • Focus on neurodevelopmental disorders, growth, respiratory illness, and well-being.
  • Examination of perinatal brain damage, bronchopulmonary dysplasia, inflammation, and socioeconomic factors.

Main Results:

  • Extremely preterm infants have increased risks for most neurodevelopmental disorders.
  • Perinatal factors (brain damage, BPD, inflammation) and prenatal socioeconomic position contribute to risk.
  • Males face higher risks for adverse outcomes; neurodevelopmental impairment impacts quality of life.

Conclusions:

  • Early life and prenatal factors significantly influence neurodevelopmental outcomes in extremely preterm infants.
  • Interventions are crucial for preventing premature birth and mitigating adverse neurodevelopmental effects.
  • Targeted postnatal support can improve the long-term life course for these individuals.